358 related articles for article (PubMed ID: 34940095)
21. T-Cell Lymphomas, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.
Horwitz SM; Ansell S; Ai WZ; Barnes J; Barta SK; Brammer J; Clemens MW; Dogan A; Foss F; Ghione P; Goodman AM; Guitart J; Halwani A; Haverkos BM; Hoppe RT; Jacobsen E; Jagadeesh D; Jones A; Kallam A; Kim YH; Kumar K; Mehta-Shah N; Olsen EA; Rajguru SA; Rozati S; Said J; Shaver A; Shea L; Shinohara MM; Sokol L; Torres-Cabala C; Wilcox R; Wu P; Zain J; Dwyer M; Sundar H
J Natl Compr Canc Netw; 2022 Mar; 20(3):285-308. PubMed ID: 35276674
[TBL] [Abstract][Full Text] [Related]
22. Angioimmunoblastic T-cell lymphoma: more than a disease of T follicular helper cells.
Lemonnier F; Mak TW
J Pathol; 2017 Aug; 242(4):387-390. PubMed ID: 28543514
[TBL] [Abstract][Full Text] [Related]
23. Primary cutaneous peripheral T-cell lymphomas with a T-follicular helper phenotype: an integrative clinical, pathological and molecular case series study.
Wang L; Rocas D; Dalle S; Sako N; Pelletier L; Martin N; Dupuy A; Tazi N; Balme B; Vergier B; Beylot-Barry M; Carlotti A; Bagot M; Battistella M; Chaby G; Ingen-Housz-Oro S; Gaulard P; Ortonne N
Br J Dermatol; 2022 Dec; 187(6):970-980. PubMed ID: 35895386
[TBL] [Abstract][Full Text] [Related]
24. Follicular Helper T-Cell-derived Nodal Lymphomas: Study of Histomorphologic, Immunophenotypic, Clinical, and RHOA G17V Mutational Profile.
Jain S; Goswami A; Lone MR; Ramteke P; Gogia A; Aggarwal M; Viswanathan GK; Kakkar D; Mandal T; Sharma A; Sahoo R; Baldia A; Sharma MC; Bakhshi S; Pramanik R; Dhawan R; Kumar L; Mallick S
Appl Immunohistochem Mol Morphol; 2023 Mar; 31(3):172-180. PubMed ID: 36806188
[TBL] [Abstract][Full Text] [Related]
25. Clinicopathological implications of immunohistochemical expression of TBX21, CXCR3, GATA3, CCR4, and TCF1 in nodal follicular helper T-cell lymphoma and peripheral T-cell lymphoma, not otherwise specified.
Han B; Lim S; Yim J; Song YK; Koh J; Kim S; Lee C; Kim YA; Jeon YK
J Pathol Transl Med; 2024 Mar; 58(2):59-71. PubMed ID: 38247153
[TBL] [Abstract][Full Text] [Related]
26. Clonal haematopoiesis: A common progenitor for cytotoxic peripheral T-cell lymphoma and angioimmunoblastic T-cell lymphoma.
Vogelsberg A; Harland L; Borgmann V; Otto F; Weller JF; Nann D; Quintanilla-Martinez L; Fend F
Br J Haematol; 2024 May; 204(5):2071-2076. PubMed ID: 38323682
[TBL] [Abstract][Full Text] [Related]
27. Peripheral T-cell lymphoma with a T follicular-helper phenotype: A different entity? Results of the Spanish Real-T study.
Martín García-Sancho A; Rodríguez-Pinilla SM; Domingo-Domenech E; Climent F; Sánchez-Garcia J; López Jiménez J; García-Cosío Piqueras M; Castellvi J; González AJ; González de Villambrosia S; Gómez Codina J; Navarro B; Rodríguez G; Borrero JJ; Fraga M; Naves A; Baeza L; Córdoba R
Br J Haematol; 2023 Oct; 203(2):182-193. PubMed ID: 37386897
[TBL] [Abstract][Full Text] [Related]
28. How I Diagnose Angioimmunoblastic T-Cell Lymphoma.
Xie Y; Jaffe ES
Am J Clin Pathol; 2021 Jun; 156(1):1-14. PubMed ID: 34117736
[TBL] [Abstract][Full Text] [Related]
29. Comprehensive analysis of clinical, pathological, and genomic characteristics of follicular helper T-cell derived lymphomas.
Yoon SE; Cho J; Kim YJ; Ko YH; Park WY; Kim SJ; Kim WS
Exp Hematol Oncol; 2021 May; 10(1):33. PubMed ID: 33990228
[TBL] [Abstract][Full Text] [Related]
30. Epigenetic focus on angioimmunoblastic T-cell lymphoma: pathogenesis and treatment.
Tari G; Lemonnier F; Morschhauser F
Curr Opin Oncol; 2021 Sep; 33(5):400-405. PubMed ID: 34230442
[TBL] [Abstract][Full Text] [Related]
31. TET-2 mutations predict poor outcomes and are associated with unfavorable clinical-biological features in PTCL, not otherwise specified and angioimmunoblastic T-cell lymphoma in Brazilian patients.
de Pádua Covas Lage LA; Barreto GC; Culler HF; Cavalcante JB; de Oliveira Alves LB; Nardinelli L; Bendit I; Zerbini MCN; Rocha V; Pereira J
Cancer Biomark; 2022; 35(2):179-191. PubMed ID: 36093687
[TBL] [Abstract][Full Text] [Related]
32. Mutation analysis links angioimmunoblastic T-cell lymphoma to clonal hematopoiesis and smoking.
Cheng S; Zhang W; Inghirami G; Tam W
Elife; 2021 Sep; 10():. PubMed ID: 34581268
[TBL] [Abstract][Full Text] [Related]
33. Angioimmunoblastic T-cell lymphoma: treatment strategies and prognostic factors from a retrospective multicenter study in China.
Zhang C; Mi L; Wu M; Liu W; Ma H; Ren J; Zhao L; Wang X; Song Y; Zhu J
Leuk Lymphoma; 2022 May; 63(5):1152-1159. PubMed ID: 34957894
[TBL] [Abstract][Full Text] [Related]
34. Comparison of prognostic scores in transplant-ineligible patients with peripheral T-cell lymphoma not otherwise specified and angioimmunoblastic T-cell lymphoma: a retrospective study from the national hospital organization in Japan.
Yamasaki S; Iida H; Yoshida I; Komeno T; Sawamura M; Matsumoto M; Sekiguchi N; Hishita T; Sunami K; Shimomura T; Takatsuki H; Yoshida S; Otsuka M; Kato T; Kuroda Y; Ooyama T; Suzuki Y; Ohshima K; Nagai H; Iwasaki H
Leuk Lymphoma; 2021 Apr; 62(4):819-827. PubMed ID: 33167741
[TBL] [Abstract][Full Text] [Related]
35. Angioimmunoblastic T-Cell Lymphoma with Polyarthritis Resembling Rheumatoid Arthritis.
Yachoui R; Farooq N; Amos JV; Shaw GR
Clin Med Res; 2016 Dec; 14(3-4):159-162. PubMed ID: 28188140
[TBL] [Abstract][Full Text] [Related]
36. Clinical spectrum, evolution, and management of autoimmune cytopenias associated with angioimmunoblastic T-cell lymphoma.
Crickx E; Poullot E; Moulis G; Goulabchand R; Fieschi C; Galicier L; Meignin V; Coppo P; Delarue R; Casasnovas O; Roos-Weil D; de Leval L; Parrens M; Michel M; Dupuis J; Le Bras F; Fataccioli V; Martin-Garcia N; Godeau B; Haïoun C; Gaulard P; Mahévas M
Eur J Haematol; 2019 Jul; 103(1):35-42. PubMed ID: 30985955
[TBL] [Abstract][Full Text] [Related]
37. Peripheral T-cell lymphoma: molecular profiling recognizes subclasses and identifies prognostic markers.
Rodríguez M; Alonso-Alonso R; Tomás-Roca L; Rodríguez-Pinilla SM; Manso-Alonso R; Cereceda L; Borregón J; Villaescusa T; Córdoba R; Sánchez-Beato M; Fernández-Miranda I; Betancor I; Bárcena C; García JF; Mollejo M; García-Cosio M; Martin-Acosta P; Climent F; Caballero D; de la Fuente L; Mínguez P; Kessler L; Scholz C; Gualberto A; Mondéjar R; Piris MA
Blood Adv; 2021 Dec; 5(24):5588-5598. PubMed ID: 34592752
[TBL] [Abstract][Full Text] [Related]
38. Management of Angioimmunoblastic T-Cell Lymphoma (AITL) and other T Follicular Helper Cell lymphomas (TFH PTCL).
Ma H; O'Connor OA; Marchi E
Semin Hematol; 2021 Apr; 58(2):95-102. PubMed ID: 33906727
[TBL] [Abstract][Full Text] [Related]
39. Ultra-high level of serum soluble interleukin-2 receptor at diagnosis predicts poor outcome for angioimmunoblastic T-cell lymphoma.
Shiratori S; Kosugi-Kanaya M; Shigematsu A; Kobayashi H; Yamamoto S; Kobayashi N; Iwasaki H; Mori A; Kunieda Y; Yutaka T; Kurosawa M; Kakinoki Y; Endo T; Kondo T; Hashino S; Teshima T;
Leuk Lymphoma; 2015; 56(9):2592-7. PubMed ID: 25563559
[TBL] [Abstract][Full Text] [Related]
40. Early detection of T-cell lymphoma with T follicular helper phenotype by RHOA mutation analysis.
Dobson R; Du PY; Rásó-Barnett L; Yao WQ; Chen Z; Casa C; Ei-Daly H; Farkas L; Soilleux E; Wright P; Grant JW; Rodriguez-Justo M; Follows GA; Rashed H; Fabre M; Baxter EJ; Vassiliou G; Wotherspoon A; Attygalle AD; Liu H; Du MQ
Haematologica; 2022 Feb; 107(2):489-499. PubMed ID: 33567811
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
